LV14878A - Vairogdziedzera papillāra vēža riska noteikšanas paņēmiens pacientiem ar vairogdziedzera mezgliem - Google Patents

Vairogdziedzera papillāra vēža riska noteikšanas paņēmiens pacientiem ar vairogdziedzera mezgliem

Info

Publication number
LV14878A
LV14878A LVP-14-20A LV140020A LV14878A LV 14878 A LV14878 A LV 14878A LV 140020 A LV140020 A LV 140020A LV 14878 A LV14878 A LV 14878A
Authority
LV
Latvia
Prior art keywords
patients
risk assessment
cancer risk
thyroid
nodules
Prior art date
Application number
LVP-14-20A
Other languages
English (en)
Other versions
LV14878B (lv
Inventor
Artūrs OZOLIŅŠ
Jānis Gardovskis
Zenons NARBUTS
Kaspars STEPANOVS
Pēteris Priedītis
Original Assignee
Rīgas Stradiņa Universitāte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rīgas Stradiņa Universitāte filed Critical Rīgas Stradiņa Universitāte
Priority to LVP-14-20A priority Critical patent/LV14878B/lv
Publication of LV14878A publication Critical patent/LV14878A/lv
Publication of LV14878B publication Critical patent/LV14878B/lv

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Izgudrojums attiecas uz endokrinoloģiju un ģenētiskajām izmeklēšanas metodēm. Tiek piedāvāts paņēmiens vairogdziedzera papilārā vēža riska noteikšanai pacientiem ar vairogdziedzera mezgliem, kurā par biomarķieri izmanto HBME-1. Ja HBME-1 ekspresija vairogdziedzera mezgla šūnās ir 2,68 un lielāka, nosaka augstu vēža rašanās risku.
LVP-14-20A 2014-02-25 2014-02-25 Vairogdziedzera papillāra vēža riska noteikšanas paņēmiens pacientiem ar vairogdziedzera mezgliem LV14878B (lv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVP-14-20A LV14878B (lv) 2014-02-25 2014-02-25 Vairogdziedzera papillāra vēža riska noteikšanas paņēmiens pacientiem ar vairogdziedzera mezgliem

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-14-20A LV14878B (lv) 2014-02-25 2014-02-25 Vairogdziedzera papillāra vēža riska noteikšanas paņēmiens pacientiem ar vairogdziedzera mezgliem

Publications (2)

Publication Number Publication Date
LV14878A true LV14878A (lv) 2014-06-20
LV14878B LV14878B (lv) 2014-10-20

Family

ID=50941955

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-14-20A LV14878B (lv) 2014-02-25 2014-02-25 Vairogdziedzera papillāra vēža riska noteikšanas paņēmiens pacientiem ar vairogdziedzera mezgliem

Country Status (1)

Country Link
LV (1) LV14878B (lv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115792247A (zh) * 2023-02-09 2023-03-14 杭州市第一人民医院 蛋白组合在制备甲状腺乳头状癌风险辅助分层系统中的应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115792247A (zh) * 2023-02-09 2023-03-14 杭州市第一人民医院 蛋白组合在制备甲状腺乳头状癌风险辅助分层系统中的应用
CN115792247B (zh) * 2023-02-09 2023-09-15 杭州市第一人民医院 蛋白组合在制备甲状腺乳头状癌风险辅助分层系统中的应用

Also Published As

Publication number Publication date
LV14878B (lv) 2014-10-20

Similar Documents

Publication Publication Date Title
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
NZ731467A (en) Anti-tim3 antibodies and methods of use
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
MX2017003933A (es) Metodos de tratamiento de la enfermedad hepatica.
EP3170094A4 (en) Method and system for robust tagging of named entities in the presence of source or translation errors
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MX369067B (es) Método para reducir la producción de gas total y/o la producción de metano en un animal rumiante.
PH12017500293A1 (en) Boronic acid derivatives
SG10201804505VA (en) Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
MX2016004865A (es) Metodo y dispositivo para analizar relacion social.
EP3192517A4 (en) Method for enhancing immune cell function and method for assessing immune cell multifunctionality
MX2017004037A (es) Derivados de acido boronico.
MX2016009858A (es) Fusiones anti proteína convertasa subtilisina/kexina tipo 9 (anti-pcsk9)n péptido 1 similar a glucagón (glp-1) y métodos de uso.
EP3161650A4 (en) Method and apparatus of usb 3.1 retimer presence detect and index
MX2017004046A (es) Derivados de acido boronico.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2019006005A (es) Metodos para la deteccion de cancer.
GB201621403D0 (en) Data processing system and method for financial or non-financial data
SG11201609677WA (en) Method for reducing the chlorine content of organomonophosphites using dimethylaminobutane, triethylamine or triethanolamine
MX2016015163A (es) Biomarcadores mit y metodos para su uso.
EP3145516A4 (en) Methods and compositions for treating malignancies with dendritic cells
EP3098311A4 (en) Method for measuring modified nucleobase using guide probe, and kit therefor
BR112017006593A2 (pt) método para detectar câncer de ovário
EA201891478A1 (ru) Способы и композиции для оценки риска возникновения рака